Exploring Alternative Funding Opportnities for Dilution Limitation, Accelerated Commercial Transactions & Value Creation
06 Sep 2023
15:30
15:30pm Chair Introduction
To be Confirmed
15:35pm Presentation: Title to be Confirmed
- Bulletpoint 1
- Bulletpoint 2
- Bulletpoint 3
Sven Kili, Chief Executive Officer, Antion Biosciences
15:50pm Presentation: Title to be Confirmed
- Bulletpoint 1
- Bulletpoint 2
- Bulletpoint 3
Ayal Ronen, Chief Business Officer, Freemind
16:05 Presentation: Title to be Confirmed
- Bulletpoint 1
- Bulletpoint 2
- Bulletpoint 3
Daniella Kranjac, Founder, Dynamk Capital
16:20pm Presentation: Title to be Confirmed
- Bulletpoint 1
- Bulletpoint 2
- Bulletpoint 3
Presenter to be Confirmed
16:35pm Closing Panel with Q&A
With all session participants
